BioSenic SA
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
BIOS | BR
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
BioSenic SA is a biotechnology company focused on developing innovative clinical-stage therapies for autoimmune diseases and regenerative medicine. The company's pipeline is centered on two main platforms: a novel treatment using arsenic trioxide (ATO) to target the underlying causes of autoimmune and inflammatory conditions, and an allogeneic cell therapy platform aimed at tissue repair and organ regeneration. Formerly known as Bone Therapeutics, BioSenic combines its expertise in immunomodulation and cell therapy to address significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-01 17:20 |
Regulatory Filings
BioS - 2nd EGM - Signed deed(1525437.1).pdf
|
French | 2.4 MB | ||
| 2025-11-12 10:00 |
Regulatory Filings
BioSenic SA_Proxy EGM_FR_OC draft 2025 11 07(1518280.1).pdf
|
French | 322.9 KB | ||
| 2025-11-12 10:00 |
Regulatory Filings
BioSenic - Expédition - 30.10.2025.pdf
|
French | 653.3 KB | ||
| 2025-11-12 10:00 |
Regulatory Filings
BioSenic SA_Convening notice_2025_FR_2025 11 04(1506176.1).pdf
|
French | 302.6 KB | ||
| 2025-11-12 10:00 |
Regulatory Filings
BioSenic SA_ Information on shareholders' rights EGM_FR_2025 11 07(1506226.1).p…
|
French | 152.9 KB | ||
| 2025-11-12 10:00 |
Regulatory Filings
BIOS_PR_GMs-2025_FR_2025 11 07(1506246.1).pdf
|
French | 214.9 KB | ||
| 2025-11-12 10:00 |
Regulatory Filings
BioSenic - Expédition - 30.10.2025.pdf
|
French | 653.3 KB | ||
| 2025-11-12 10:00 |
Regulatory Filings
BioSenic - Expédition - 30.10.2025.pdf
|
French | 653.3 KB | ||
| 2025-10-28 07:00 |
Interim / Quarterly Report
BIOS_H1-PR Report_FR_2025 10 28_final.pdf
|
French | 371.5 KB | ||
| 2025-09-29 22:00 |
Pre-Annual General Meeting Information
BioSenic SA_ Information on shareholders' rights GMs_FR_2025 09 29.pdf
|
French | 160.6 KB | ||
| 2025-09-29 22:00 |
Share Issue/Capital Change
BioSenic - (FR) Warrant_Plan - 2025 09 29.pdf
|
French | 316.3 KB | ||
| 2025-09-29 22:00 |
Management Reports
BioSenic - Rapport de gestion - 20250929-final.pdf
|
French | 616.8 KB | ||
| 2025-09-29 22:00 |
Audit Report / Information
BioSenic SA-rapport du commissaire-31 12 2024_signed.pdf
|
French | 1.6 MB | ||
| 2025-09-29 22:00 |
Management Reports
BioSenic___Rapport_spécial_CA_(Art_7_228_CSA)_2025_09_29.docx.pdf
|
French | 348.2 KB | ||
| 2025-09-29 22:00 |
Annual Report
20250817_Rapport annuel 2024_FR_Final.pdf
|
French | 2.0 MB |
Automate Your Workflow. Get a real-time feed of all BioSenic SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioSenic SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioSenic SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-16 | Rieger Francois | Board | Sell | 2,500,000 | 25,000.00 EUR |
| 2024-08-06 | Rieger Francois | Board | Sell | 868,653 | 7,186.87 EUR |
| 2024-08-05 | POMI SCHNEITER VERONIQUE | Board | Sell | 534,750 | 4,331.47 EUR |
| 2024-08-02 | POMI SCHNEITER VERONIQUE | Board | Sell | 193,900 | 1,609.37 EUR |
| 2024-08-01 | Rieger Francois | Board | Sell | 1,236,684 | 11,463.87 EUR |
| 2024-08-01 | POMI SCHNEITER VERONIQUE | Board | Sell | 140,003 | 1,246.03 EUR |
| 2024-07-31 | POMI SCHNEITER VERONIQUE | Board | Sell | 503,771 | 4,685.07 EUR |
| 2024-07-30 | POMI SCHNEITER VERONIQUE | Board | Sell | 360,021 | 3,348.20 EUR |
| 2024-07-29 | POMI SCHNEITER VERONIQUE | Board | Sell | 372,893 | 3,430.62 EUR |
| 2024-07-24 | POMI SCHNEITER VERONIQUE | Board | Sell | 2,168,361 | 21,033.10 EUR |
Peer Companies
